Burzynski Research Institute, Inc. (BZYR)

Market Cap	26.29K -99.5%
Revenue (ttm)	n/a
Net Income	-1.29M
EPS	-0.01
Shares Out	131.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Open	0.0002
Previous Close	n/a
Day's Range	0.0002 - 0.0002
52-Week Range	0.0002 - 0.0470
Beta	0.43
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 21, 2026

About BZYR

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1977
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: BZYR

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 20, 2026

Data Sources Report a data error